Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 5:06 PM View:  | Abbvie Inc. (ABBV) | 24-Sep-24 | Gift | 25,630 | -- | -- | (11%) 226.17K to 200.54K | |
| 25-Apr-24 1:45 PM View: | Entegris Inc. (ENTG) | 24-Apr-24 | Grant | 1,643 | -- | -- | 8% 20.43K to 22.07K | |
| 01-Mar-24 5:50 PM View: | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 23,966 | $178.99 | $4,289,670.00 | (10%) 250.14K to 226.17K | |
| 23-Feb-24 5:00 PM View: | Abbvie Inc. (ABBV) | 21-Feb-24 | Option Exercise | 52,870 | $58.88 | $3,112,990.00 | 21% 250.14K to 303.01K | |
| 23-Feb-24 5:00 PM View: | Abbvie Inc. (ABBV) | 21-Feb-24 | Option Sale | 52,870 | $173.71 | $9,184,050.00 | (17%) 303.01K to 250.14K | |
| 20-Feb-24 5:23 PM View: | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 54,095 | -- | -- | 28% 196.04K to 250.14K | |
| 28-Apr-23 4:02 PM View: | Entegris Inc. (ENTG) | 26-Apr-23 | Grant | 2,849 | -- | -- | 16% 17.58K to 20.43K | |
| 02-Mar-23 5:01 PM View: | Abbvie Inc. (ABBV) | 01-Mar-23 | Option Exercise | 26,990 | $51.42 | $1,387,830.00 | 13% 206.04K to 233.03K | |
| 02-Mar-23 5:01 PM View: | Abbvie Inc. (ABBV) | 01-Mar-23 | Option Sale | 26,990 | $154.48 | $4,169,420.00 | (12%) 233.03K to 206.04K | |
| 02-Mar-23 5:01 PM View: | Abbvie Inc. (ABBV) | 01-Mar-23 | Sale | 10,000 | $154.48 | $1,544,800.00 | (5%) 206.04K to 196.04K | |
| 02-Mar-23 5:01 PM View: | Abbvie Inc. (ABBV) | 28-Feb-23 | Payment of Exercise | 33,359 | $154.28 | $5,146,630.00 | (14%) 239.4K to 206.04K | |
| 21-Feb-23 6:13 PM View: | Abbvie Inc. (ABBV) | 17-Feb-23 | Option Exercise | 25,000 | $51.42 | $1,285,500.00 | 10% 239.4K to 264.4K | |
| 21-Feb-23 6:13 PM View: | Abbvie Inc. (ABBV) | 17-Feb-23 | Option Sale | 25,000 | $149.53 | $3,738,140.00 | (9%) 264.4K to 239.4K | |
| 21-Feb-23 6:13 PM View: | Abbvie Inc. (ABBV) | 16-Feb-23 | Grant | 75,296 | -- | -- | 46% 164.11K to 239.4K | |
| 29-Apr-22 4:16 PM View: | Entegris Inc. (ENTG) | 27-Apr-22 | Grant | 1,849 | -- | -- | 12% 15.73K to 17.58K | |
| 01-Mar-22 10:00 PM View: | Abbvie Inc. (ABBV) | 25-Feb-22 | Payment of Exercise | 22,108 | $149.54 | $3,306,030.00 | (12%) 186.22K to 164.11K | |
| 22-Feb-22 5:40 PM View: | Abbvie Inc. (ABBV) | 17-Feb-22 | Grant | 63,736 | -- | -- | 52% 122.48K to 186.22K | |
| 26-May-21 5:20 PM View: | Abbvie Inc. (ABBV) | 24-May-21 | Option Exercise | 86,920 | $34.93 | $3,036,230.00 | 71% 122.43K to 209.35K | |
| 26-May-21 5:20 PM View: | Abbvie Inc. (ABBV) | 24-May-21 | Market Option Sale | 86,920 | $116.29 | $10,108,000.00 | (42%) 209.35K to 122.43K | |
| 03-May-21 4:12 PM View: | Entegris Inc. (ENTG) | 29-Apr-21 | Grant | 1,610 | -- | -- | 11% 14.12K to 15.73K | |
| 02-Mar-21 8:31 PM View: | Abbvie Inc. (ABBV) | 28-Feb-21 | Payment of Exercise | 15,785 | $107.74 | $1,700,680.00 | (11%) 138.13K to 122.35K | (< 1%) |
| 22-Feb-21 6:23 PM View: | Abbvie Inc. (ABBV) | 18-Feb-21 | Grant | 35,628 | -- | -- | 35% 102.51K to 138.13K | |
| 12-Nov-20 5:56 PM View: | Abbvie Inc. (ABBV) | 10-Nov-20 | Market Sale | 17,426 | $98.00 | $1,707,750.00 | (15%) 119.93K to 102.51K | (5%) |
| 06-Nov-20 4:29 PM View: | Abbvie Inc. (ABBV) | 04-Nov-20 | Market Sale (Planned) | 4,800 | $93.61 | $449,328.00 | (4%) 119.77K to 114.97K | (10%) |
| 01-May-20 4:29 PM View: | Entegris Inc. (ENTG) | 29-Apr-20 | Grant | 2,567 | -- | -- | 22% 11.56K to 14.12K | |
| 03-Mar-20 4:56 PM View: | Abbvie Inc. (ABBV) | 28-Feb-20 | Payment of Exercise | 16,342 | $85.42 | $1,395,930.00 | (12%) 136.11K to 119.77K | (16%) |
| 24-Feb-20 6:00 PM View: | Abbvie Inc. (ABBV) | 20-Feb-20 | Grant | 36,897 | -- | -- | 37% 99.21K to 136.11K | |
| 03-May-19 4:05 PM View: | Entegris Inc. (ENTG) | 01-May-19 | Grant | 3,569 | -- | -- | 45% 7.99K to 11.56K | |
| 06-Mar-19 5:03 PM View: | Abbvie Inc. (ABBV) | 05-Mar-19 | Market Sale | 15,797 | $79.03 | $1,248,480.00 | (14%) 115.01K to 99.21K | (21%) |
| 04-Mar-19 4:58 PM View: | Abbvie Inc. (ABBV) | 28-Feb-19 | Payment of Exercise | 12,569 | $79.41 | $998,104.00 | (10%) 127.58K to 115.01K | (21%) |
| 22-Feb-19 5:18 PM View: | Abbvie Inc. (ABBV) | 21-Feb-19 | Grant | 28,366 | -- | -- | 29% 99.21K to 127.58K | |
| 10-May-18 4:55 PM View: | Entegris Inc. (ENTG) | 09-May-18 | Grant | 4,090 | -- | -- | 105% 3.9K to 7.99K | |
| 02-Mar-18 5:31 PM View: | Abbvie Inc. (ABBV) | 28-Feb-18 | Payment of Exercise | 12,683 | $118.26 | $1,499,890.00 | (11%) 113.15K to 100.47K | 20% |
| 02-Mar-18 5:31 PM View: | Abbvie Inc. (ABBV) | 28-Feb-18 | Market Sale | 1,337 | $117.77 | $157,458.00 | (1%) 100.47K to 99.13K | 20% |
| 16-Feb-18 5:51 PM View: | Abbvie Inc. (ABBV) | 15-Feb-18 | Grant | 22,533 | -- | -- | 25% 90.6K to 113.14K | |
| 12-Sep-17 5:40 PM View: | Abbvie Inc. (ABBV) | 11-Sep-17 | Option Exercise | 4,800 | $24.21 | $116,199.00 | 5% 94.09K to 98.89K | |
| 12-Sep-17 5:40 PM View: | Abbvie Inc. (ABBV) | 11-Sep-17 | Market Option Sale | 4,800 | $85.02 | $408,090.00 | (5%) 98.89K to 94.09K | (9%) |
| 12-Sep-17 5:40 PM View: | Abbvie Inc. (ABBV) | 11-Sep-17 | Market Sale | 3,500 | $85.02 | $297,566.00 | (4%) 94.09K to 90.59K | (9%) |
| 15-Aug-17 5:03 PM View: | Entegris Inc. (ENTG) | 14-Aug-17 | Grant | 3,897 | -- | -- | 100% 0 to 3.9K | |
| 02-Mar-17 6:13 PM View: | Abbvie Inc. (ABBV) | 28-Feb-17 | Payment of Exercise | 19,096 | $62.22 | $1,188,150.00 | (17%) 113.15K to 94.06K | (46%) |
| 21-Feb-17 5:52 PM View: | Abbvie Inc. (ABBV) | 16-Feb-17 | Grant | 22,816 | -- | -- | 25% 90.33K to 113.15K | |
| 03-Feb-17 5:21 PM View: | Abbvie Inc. (ABBV) | 02-Feb-17 | Payment of Exercise | 1,558 | $60.89 | $94,866.60 | (2%) 91.87K to 90.31K | (50%) |
| 03-Feb-17 5:21 PM View: | Abbvie Inc. (ABBV) | 02-Feb-17 | Option Exercise | 2,400 | $27.29 | $65,496.00 | 3% 89.47K to 91.87K | |
| 02-Mar-16 5:25 PM View: | Abbvie Inc. (ABBV) | 29-Feb-16 | Payment of Exercise | 13,608 | $56.00 | $762,048.00 | (13%) 104.81K to 91.2K | (66%) |
| 02-Mar-16 5:25 PM View: | Abbvie Inc. (ABBV) | 29-Feb-16 | Market Sale | 1,776 | $55.38 | $98,349.50 | (2%) 91.2K to 89.42K | (67%) |
| 09-Feb-16 5:13 PM View: | Abbvie Inc. (ABBV) | 05-Feb-16 | Payment of Exercise | 2,112 | $56.76 | $119,877.00 | (2%) 106.9K to 104.79K | (63%) |
| 09-Feb-16 5:13 PM View: | Abbvie Inc. (ABBV) | 05-Feb-16 | Option Exercise | 3,400 | $22.94 | $77,998.40 | 3% 103.5K to 106.9K | |
| 03-Mar-15 6:09 PM View: | Abbvie Inc. (ABBV) | 28-Feb-15 | Payment of Exercise | 4,592 | $60.50 | $277,816.00 | (4%) 108.05K to 103.46K | (59%) |
| 03-Mar-15 6:09 PM View: | Abbvie Inc. (ABBV) | 27-Feb-15 | Payment of Exercise | 5,901 | $60.52 | $357,129.00 | (5%) 116.06K to 110.16K | (59%) |
| 03-Mar-15 6:09 PM View: | Abbvie Inc. (ABBV) | 27-Feb-15 | Market Sale | 2,112 | $60.47 | $127,706.00 | (2%) 110.16K to 108.05K | (59%) |